Latest news and articles about new treatments from NEX English
Recent studies have revealed promising signals that could help in the fight against the novel coronavirus. These discoveries open new avenues in medical research at a critical time as the world continues to grapple with the pandemic's effects.
Reports indicate that the U.S. Food and Drug Administration (FDA) intends to permit the production of 14 peptides that were previously banned due to safety concerns. This decision comes amid increasing calls for the use of these substances in medical treatments.
Biogen, a company specializing in drug development, has announced its acquisition of Apellis Pharmaceuticals for <strong>$5.6 billion</strong>. This move aims to expand Biogen's capabilities in treating kidney diseases, addressing the growing need for effective therapies.
Merck & Co. is in advanced talks to acquire Turners Pharmaceuticals, a move aimed at strengthening its portfolio of drugs and treatments. This acquisition reflects Merck's strategy to expand its presence in the global pharmaceutical market.